Results from the pilot study showed that the high-DHA concentrate may indeed modulate human B-cell activity in middle-aged obese adults, but the study’s authors stressed the need for further testing in a larger cohort.
Omega-3s are poised for a comeback, thanks to innovation in the category and new research initiatives.
GOED issued a statement to its members affirming several points, including that the meta-analysis, which showed that omega-3 fatty acid supplementation had no significant associations with CHD death, nonfatal myocardial infarction, any coronary heart disease events, or major vascular events, adds little to the current body of evidence surrounding omega-3s and cardiovascular risk factors.
The acquisition is part of Frutarom’s merger plan to “enable the rapid, efficient, and comprehensive integration of the global activities of both companies.”
The novel omega-3 technology is designed to accelerate the nutrient’s absorption and ensure its delivery to the sites where the body most needs it.
The report has been posted to the Codex Alimentarius Commission website.
The “GOED Best-Practice Guidelines on Oxidation Control” were developed to help GOED members prevent and minimize the risk of oxidation that threatens omega-3 oils at multiple points along the value chain, from processing to the encounter with the consumer.
The latest research on brain health ingredients indicates products are meeting consumer needs and offer significant opportunity for category growth.
A look at why CoQ10 has remained a go-to heart health ingredient for decades.
In its response, the ITC stated that “Amarin’s complaint does not allege an unfair method of competition or an unfair act cognizable under 19 U.S.C. § 1337(a)(1)(A), as required by the statute and the Commission’s rules.”